Ocular Science is a biotech company reducing dry eye and inflammation through post-operative care.
Ocular Science has raised $16.5M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2026.
Ocular Science's investors include Chicago Atlantic Group.
Ocular Science is headquartered in Manhattan Beach, United States.
Ocular Science is a biotech company reducing dry eye and inflammation through post-operative care.
Ocular Science is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ocular Science — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/ocular-science. Accessed August 14, 2026.
VCBacked. (2026). Ocular Science — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ocular-science
{{cite web |title=Ocular Science — Funding & Investors |url=https://www.vcbacked.co/company/ocular-science |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated